Detalhe da pesquisa
1.
Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo.
Bioorg Med Chem Lett
; 98: 129590, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092072
2.
Design, synthesis and structure-activity relationship of 1,8-naphthalimide derivatives as highly potent hCYP1B1 inhibitors.
Bioorg Med Chem Lett
; 107: 129776, 2024 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692523
3.
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
J Transl Med
; 21(1): 858, 2023 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012658
4.
One step stereoselective synthesis of oxazoline-fused saccharides and their conversion into the corresponding 1,2-cis glycosylamines bearing various protected groups.
Org Biomol Chem
; 19(7): 1580-1588, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33522535
5.
Synthesis and Structure-Activity Relationships of 3-Arylisoquinolone Analogues as Highly Specific hCES2A Inhibitors.
ChemMedChem
; 16(2): 388-398, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935462